SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is trending due to its rapidly expanding ecosystem, evidenced by rising TVL, app revenue, and user growth, driven by its advanced ZK-STARK technology, increasing Bitcoin DeFi integrations, and ongoing focus on quantum resistance and privacy. The community widely discusses its robust long-term infrastructure build, viewing current valuations as a potential mispricing despite recent token unlock conversations.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following news of a public stock offering and a substantial royalty funding agreement, which the community is debating as either a necessary strategic capital raise to advance its oncology pipeline and meet financial obligations, or as a significant, ill-timed dilution impacting short-term share value.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is highly debated after trial results for its multi-cancer early detection test missed a primary endpoint for statistically significant reduction in late-stage diagnoses. This has fueled a polarized discussion between those seeing an overreaction given the test's strong detection capabilities and ample cash runway, and others expressing significant concern for the company's future.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending due to its recent Q4 earnings report, which highlighted strong revenue growth and expanding user base but also a net loss and a softer Q1 outlook. This mixed performance has ignited a contentious debate among investors, who are weighing the company's "buy now, pay later" business model and profitability challenges against its market penetration and strategic partnerships.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - 8% PRF PERPETUAL USD 100 - Ser A

Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock

Strategy Inc's 8.00% Series A Perpetual Strike Preferred Stock ($STRK) is a focal point of conversation, with investors debating its attractive dividend yield and direct correlation to MicroStrategy's Bitcoin acquisition strategy. However, the community also expresses notable concerns over potential dividend sustainability, dilution risks from new preferred offerings, and its value relative to other MicroStrategy preferred shares.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending following its strong Q4 earnings report, which highlighted record revenue, a significant profit turnaround, and impressive premiums from its direct-to-consumer silver sales. The community is overwhelmingly bullish, anticipating a major breakout driven by these robust fundamentals and broader tailwinds from increasing physical silver demand and a tightening COMEX supply.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token ($VVV) is trending amid significant token supply reductions, including burns and reduced emissions, alongside surging platform activity and strategic partnerships in the privacy-focused AI sector. The community is highly optimistic, discussing its unique uncensored AI offerings and low circulating supply as key drivers for substantial future growth.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending after reporting strong Q4 earnings and record free cash flow, though its mixed 2026 production and cost guidance has led to a 'sell the news' reaction. Despite the immediate dip, community discussion is vibrant with many viewing it as a buying opportunity, anticipating a continued parabolic rise for gold and the mining sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending with high anticipation for its upcoming Investor Day, where new data on its best-in-class sonelokimab nanobody is expected, driving community excitement amidst significant institutional share repurchases and speculation about a potential short squeeze from its current undervaluation.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is trending as institutional adoption accelerates, highlighted by a major European asset manager tokenizing a fund on its network and widespread discussion about its foundational role for stablecoins and Layer 2 solutions. The community is actively anticipating network enhancements while viewing market volatility as an opportunity for accumulation by smart money.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Health In Tech, Inc. (NASDAQ:HIT) Short Interest Update

Health In Tech, Inc. (NASDAQ:HIT - Get Free Report) saw a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 162,725 shares, a decline of...

Health In Tech (NASDAQ:HIT) Trading Down 5.7% - Should You Sell?

Health In Tech (NASDAQ:HIT) Trading Down 5.7% - Time to Sell...

Health In Tech (NASDAQ:HIT) Stock Price Down 5.7% - Should You Sell?

Health In Tech (NASDAQ:HIT) Trading Down 5.7% - Here's Why...

Health In Tech, Inc. (NASDAQ:HIT - Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 269,748...

Health In Tech Unveils Full hitDavos 2026 Independent InsurTech Summit Agenda Featuring Global Leaders in Politics, AI, and Culture

Health In Tech Unveils Full hitDavos 2026 Independent InsurTech Summit Agenda Featuring Global Leaders in Politics, AI, and Culture Health In Tech Unveils Full hitDavos 2026 Independent InsurTech...

Health In Tech, Inc. (NASDAQ:HIT) Short Interest Down 68.8% in December

Health In Tech, Inc. (NASDAQ:HIT - Get Free Report) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling 132,749 shares, a decrease...

Health In Tech (NASDAQ:HIT) Stock Price Up 2.3% - What's Next?

Health In Tech (NASDAQ:HIT) Trading Up 2.3% - Here's Why...

Health In Tech Announces Voluntary Extension of Lock-Up Period

Health In Tech Announces Voluntary Extension of Lock-Up Period Health In Tech Announces Voluntary Extension of Lock-Up Period PR Newswire STUART, Fla., Dec. 2, 2025 STUART, Fla., Dec. 2, 2025...

Health In Tech (NASDAQ:HIT) Downgraded to "Hold" Rating by Wall Street Zen

Wall Street Zen lowered shares of Health In Tech from a "buy" rating to a "hold" rating in a research report on Sunday...

FY2025 EPS Estimates for Health In Tech Reduced by Analyst

Health In Tech, Inc. (NASDAQ:HIT - Free Report) - Zacks Small Cap reduced their FY2025 earnings per share (EPS) estimates for Health In Tech in a research note issued on Wednesday, November 12th...

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.01	--	--	N/A
Q3 '25	$0.01	$0.01	--	EXPECTED
Q2 '25	$0.01	$0.01	--	EXPECTED
Q1 '25	$0.01	--	--	N/A

HIT
Health In Tech Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest HIT News

HITHealth In Tech Inc. - Ordinary Shares - Class A